We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr James Gildersleve at Spire include:
Having graduated from Oxford University I completed my initial general medical training in London. I then spent five years training in Oncology at the Royal Marsden Hospital followed by two years in Leeds.
I have been the Cancer Lead at the Berkshire Cancer Centre, Reading between 1994 to 2017 and the Clinical Director between 2011 and 2017.
I sit on the faculty board of the Royal College of Radiologists.
I am a major contributor to national randomised trials investigating gastro-intestinal and lung cancer.
Head and neck oncology
Special clinical interests: Chemotherapy and radiotherapy for cancers of the intestine, head and neck and lungs
MBBS / Oxford / 1982
Bachelor of Medicine
Fellow of the Royal College of Radiologists
Fellow of the Royal College of Physicians
Member of the British Oncological Association
Consultant Clinical Oncologist, Royal Berkshire Hospital, Reading. Battle NHS TrustBack to top
I have been involved in medical education throughout my career, as tutor, educational supervisor and Deputy Regional Advisor. I was an examiner for the FRCR between 2006 and 2012.Back to top
I am on the steering committee for, and investor in, the Windsor Diagnostic and Oncology Centre. In the past I have accepted sponsorship from drug companies, to attend international oncology seminars. I no longer do so. I have no financial relationship with any pharmaceutical company.Back to top
|Telephone||0118 955 3539|
|Private secretary||Donna Gardner|
|Private secretary telephone||0118 955 3531|
|Private secretary fax||0118 955 3519|
|Private secretary firstname.lastname@example.org|
11 February 2020
Redbridge-based Spire London East Hospital has been upgraded to a ‘Good’ rating following an inspection by the Care Qual…
04 February 2020
The Paterson Independent Inquiry published its final report on 4 February 2020.